Stereotaxis Inc (STXS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.364x

Based on the latest financial reports, Stereotaxis Inc (STXS) has a cash flow conversion efficiency ratio of -0.364x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.20 Million) by net assets ($11.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Stereotaxis Inc - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Stereotaxis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Stereotaxis Inc for a breakdown of total debt and financial obligations.

Stereotaxis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stereotaxis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hanjin Transportation Co. Ltd.
KO:002320
0.031x
Bright Led Electronics Corp
TW:3031
0.015x
Dynamix Corporation
NASDAQ:ETHM
-0.003x
KG Eco Technology Services Co. Ltd
KQ:151860
0.010x
Radcom Ltd
NASDAQ:RDCM
0.022x
Marblegate Acquisition Corp
NASDAQ:GATE
0.017x
Digi Power X Inc.
V:DGX
-0.155x
Alarko Carrier Sanayi ve Ticaret AS
IS:ALCAR
-0.001x

Annual Cash Flow Conversion Efficiency for Stereotaxis Inc (2002–2024)

The table below shows the annual cash flow conversion efficiency of Stereotaxis Inc from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Stereotaxis Inc (STXS) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $11.43 Million $-8.50 Million -0.743x -78.27%
2023-12-31 $21.92 Million $-9.14 Million -0.417x -58.19%
2022-12-31 $31.93 Million $-8.41 Million -0.264x -252.70%
2021-12-31 $39.42 Million $-2.95 Million -0.075x +14.40%
2020-12-31 $40.23 Million $-3.51 Million -0.087x +46.06%
2019-12-31 $28.52 Million $-4.62 Million -0.162x +53.78%
2018-12-31 $7.27 Million $-2.55 Million -0.350x -254.38%
2017-12-31 $-20.61 Million $-4.67 Million 0.227x -46.32%
2016-12-31 $-15.53 Million $-6.56 Million 0.423x +194.59%
2015-12-31 $-17.63 Million $-2.53 Million 0.143x -80.20%
2014-12-31 $-12.55 Million $-9.09 Million 0.724x +33.90%
2013-12-31 $-11.70 Million $-6.33 Million 0.541x -16.10%
2012-12-31 $-18.79 Million $-12.12 Million 0.645x -61.54%
2011-12-31 $-18.83 Million $-31.57 Million 1.677x +192.88%
2010-12-31 $10.48 Million $-18.91 Million -1.805x +38.17%
2009-12-31 $7.64 Million $-22.31 Million -2.919x +51.39%
2008-12-31 $4.77 Million $-28.65 Million -6.006x -306.91%
2007-12-31 $24.19 Million $-35.71 Million -1.476x -69.60%
2006-12-31 $44.79 Million $-38.98 Million -0.870x +61.51%
2005-12-31 $18.13 Million $-40.99 Million -2.261x -315.04%
2004-12-31 $58.39 Million $-31.81 Million -0.545x +43.74%
2003-12-31 $25.27 Million $-24.47 Million -0.968x -5.54%
2002-12-31 $24.01 Million $-22.03 Million -0.918x --

About Stereotaxis Inc

NYSE MKT:STXS USA Medical Instruments & Supplies
Market Cap
$179.18 Million
Market Cap Rank
#17106 Global
#3929 in USA
Share Price
$1.92
Change (1 day)
+1.05%
52-Week Range
$1.73 - $3.57
All Time High
$10.17
About

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires thro… Read more